Tech Company Financing Transactions
MedRhythms Funding Round
MedRhythms, based in Boston, raised $25 million from Advantage Capital Partners, Morningside Group and Werth Family Investment Associates.
Transaction Overview
Company Name
Announced On
7/29/2021
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors
Advantage Capital Partners (Lead Investor)
Morningside Group (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand its team and key corporate functions to commercialize its flagship product for chronic stroke survivors with walking deficits and advance its digital therapeutics pipeline.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Undisclosed
Boston, MA 02101
USA
Boston, MA 02101
USA
Phone
Website
Email Address
Overview
Millions of people lose language, cognitive, and movement abilities each year. MedRhythms exists to bring them back by helping patients access the highest quality of care at the intersection of music, technology, and neuroscience.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Harris
President
Owen McCarthy
Browse more venture capital transactions:
Prev: 7/29/2021: Vira Health venture capital transaction
Next: 7/29/2021: Contentful venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries on this site are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs